As a result, AOM/DSS increased the level of IL-6, IL-11, IL-17, IL-22, IL-23, MIP-1β, and G-CSF in serum, which was partially reversed by the KI (30.0 mg/kg) treatment (Figure 4A). The gene discussed is IL17A; the disease is infectious otitis media.